LUNG CANCER (NSCLC)

This study tests a new way to treat non-small cell lung cancer. Doctors take a patient's own immune cells, train them with a special nanovaccine made from the patient's tumor, and then put them back into the body to fight the cancer. The goal is to see if these cells can safely t…

This study looks at whether calisthenic exercises (like stretches and light body-weight moves) can reduce fatigue and help lung cancer patients feel better about exercising. About 33 adults with lung cancer who are on chemotherapy, radiotherapy, or immunotherapy took part. The go…

This study looks at how immune checkpoint inhibitors, a type of immunotherapy for cancer, affect the tiny blood vessels in the heart. Researchers will use heart scans and blood tests in 25 adults with breast or lung cancer before and during treatment. The goal is to understand if…

This study involves 10,000 people with non-small cell lung cancer who received immunotherapy before surgery. Researchers want to find out which follow-up treatments work best to improve survival and prevent cancer from coming back. By analyzing real-world data, they hope to ident…

This study compares two robotic platforms, DaVinci Xi and Versius, used in lung surgery for conditions like early-stage lung cancer. Researchers will track 150 patients to see which robot leads to fewer complications, shorter hospital stays, and better value for money. Participan…

This study collects fresh tumor samples from 416 adults with various cancers (bladder, kidney, colorectal, head and neck, liver, lung, skin, endometrial) to develop and train a live tumor diagnostic platform. The goal is to see how accurately the platform can predict whether a pa…

This study looks at 248 lung cancer patients to see if the length of time they quit smoking before surgery affects their risk of problems like pneumonia or heart issues. Researchers compare recent quitters and long-term nonsmokers. The goal is to find the best timing to quit smok…

This study looks at 80 lung cancer patients with unusual or complex situations, such as rare tumor types or prior treatments, who are receiving radiotherapy. The goal is to track side effects and learn how to better manage these challenging cases. It does not test a new treatment…